Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.
Mandorfer M, Kozbial K, Freissmuth C, Schwabl P, Stättermayer AF, Reiberger T, Beinhardt S, Schwarzer R, Trauner M, Ferlitsch A, Hofer H, Peck-Radosavljevic M, Ferenci P. Mandorfer M, et al. Among authors: kozbial k. Aliment Pharmacol Ther. 2015 Sep;42(6):707-18. doi: 10.1111/apt.13315. Epub 2015 Jul 16. Aliment Pharmacol Ther. 2015. PMID: 26179884
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension.
Mandorfer M, Kozbial K, Schwabl P, Freissmuth C, Schwarzer R, Stern R, Chromy D, Stättermayer AF, Reiberger T, Beinhardt S, Sieghart W, Trauner M, Hofer H, Ferlitsch A, Ferenci P, Peck-Radosavljevic M. Mandorfer M, et al. Among authors: kozbial k. J Hepatol. 2016 Oct;65(4):692-699. doi: 10.1016/j.jhep.2016.05.027. Epub 2016 May 27. J Hepatol. 2016. PMID: 27242316
Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.
Kozbial K, Moser S, Al-Zoairy R, Schwarzer R, Datz C, Stauber R, Laferl H, Strasser M, Beinhardt S, Stättermayer AF, Gschwantler M, Zoller H, Maieron A, Graziadei I, Trauner M, Steindl-Munda P, Hofer H, Ferenci P. Kozbial K, et al. Liver Int. 2018 Jun;38(6):1028-1035. doi: 10.1111/liv.13629. Epub 2017 Dec 1. Liver Int. 2018. PMID: 29136329
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy.
Mandorfer M, Kozbial K, Schwabl P, Chromy D, Semmler G, Stättermayer AF, Pinter M, Hernández-Gea V, Fritzer-Szekeres M, Steindl-Munda P, Trauner M, Peck-Radosavljevic M, García-Pagán JC, Ferenci P, Reiberger T. Mandorfer M, et al. Among authors: kozbial k. Hepatology. 2020 Mar;71(3):1023-1036. doi: 10.1002/hep.30885. Epub 2019 Oct 14. Hepatology. 2020. PMID: 31365764 Free PMC article.
HCV targeting of patients with cirrhosis.
Ferenci P, Kozbial K, Mandorfer M, Hofer H. Ferenci P, et al. Among authors: kozbial k. J Hepatol. 2015 Oct;63(4):1015-22. doi: 10.1016/j.jhep.2015.06.003. Epub 2015 Jun 19. J Hepatol. 2015. PMID: 26100497 Review.
DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting.
Beinhardt S, Al Zoairy R, Ferenci P, Kozbial K, Freissmuth C, Stern R, Stättermayer AF, Stauber R, Strasser M, Zoller H, Watschinger B, Schmidt A, Trauner M, Hofer H, Maieron A. Beinhardt S, et al. Among authors: kozbial k. Transpl Int. 2016 Sep;29(9):999-1007. doi: 10.1111/tri.12799. Epub 2016 Jul 7. Transpl Int. 2016. PMID: 27203857 Free article.
Letter: retreatment of patients with chronic hepatitis C who have failed interferon-free combination therapy with direct acting anti-virals.
Kozbial K, Aberle SW, Susser S, Al-Zoairy R, Moser S, Stättermayer AF, Maieron A, Gschwantler M, Stauber R, Graziadei I, Zoller H, Beinhardt S, Holzmann H, Munda-Steindl P, Hofer H, Sarrazin C, Ferenci P. Kozbial K, et al. Aliment Pharmacol Ther. 2017 Jan;45(2):373-375. doi: 10.1111/apt.13887. Epub 2016 Dec 1. Aliment Pharmacol Ther. 2017. PMID: 27910121 No abstract available.
Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment.
Kozbial K, Moser S, Schwarzer R, Laferl H, Al-Zoairy R, Stauber R, Stättermayer AF, Beinhardt S, Graziadei I, Freissmuth C, Maieron A, Gschwantler M, Strasser M, Peck-Radosalvjevic M, Trauner M, Hofer H, Ferenci P. Kozbial K, et al. J Hepatol. 2016 Oct;65(4):856-858. doi: 10.1016/j.jhep.2016.06.009. Epub 2016 Jun 16. J Hepatol. 2016. PMID: 27318327 No abstract available.
21 results